scholarly article | Q13442814 |
P2093 | author name string | M Kende | |
P433 | issue | 5 | |
P921 | main subject | Rift Valley fever | Q326638 |
Rift Valley fever virus | Q14276794 | ||
Rift Valley fever phlebovirus | Q24809101 | ||
P304 | page(s) | 503-511 | |
P577 | publication date | 1985-10-01 | |
P1433 | published in | Journal of biological response modifiers | Q27711629 |
P1476 | title | Prophylactic and therapeutic efficacy of poly(I,C)-LC against Rift Valley fever virus infection in mice | |
P478 | volume | 4 |
Q64450546 | Antiviral therapeutic approaches for human rhinovirus infections |
Q35165344 | Association of symptoms and severity of rift valley fever with genetic polymorphisms in human innate immune pathways |
Q27487859 | Broad-Spectrum Drugs Against Viral Agents |
Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
Q26747457 | Phleboviruses and the Type I Interferon Response |
Q35120421 | Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice |
Q45324172 | Recent advances in the development of antiviral therapeutics for Rift Valley fever virus infection. |
Q26745530 | Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins |
Q38195597 | TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease. |
Q55379440 | Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections. |
Search more.